Developing opsin gene therapies as an alternative to opioids and electrical spinal cord stimulators to solve chronic pain!
Opsin Biotherapeutics, Inc. was founded with the goal of developing new therapies to stop chronic pain where all other therapies fail. Since then, we have demonstrated positive in vitro and in vivo results, and no adverse signals.
We have licensed a Multi-Characteristic Opsin gene and non-viral delivery method that turns pain-blocking neurons into photoreceptors. These neurons are then activated with a simple red LED. This is the next generation therapy for Spinal Cord Stimulation.
At Opsin Biotherapeutics, Inc., we are committed to ethical and responsible biotech research and development. We believe in putting patients first, and we are dedicated to developing therapies for chronic pain that are safe and effective.
Our therapies are in development and have not been approved by any regulatory agency and are not available for human use. Information provided is for educational purposes only.
Opsin Biotherapeutics, Inc.
Copyright © 2023 Opsin Biotherapeutics, Inc. - All Rights Reserved.